New England Journal of Medicine · 2020 · 78 citations · 10 references
PharmacyPharmacologyPharmacotherapyDrug DeliveryImmunopharmacologyImmunotherapyIntramuscular Drug DeliveryVasoactive MedicationsAntisense Oligonucleotide DesignAntisense RnasBradykinin-mediated AngioedemaHereditary Angioedema
at a dose of 80 mg every 3 to 4 weeks for 7 to 8 months. Treatment was accompanied by a reduction in the angioedema attack rate. (Funded by Amsterdam UMC.).
10
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks
Aleena Banerji, Marc A. Riedl, Jonathan A. Bernstein et al. · JAMA · 2018 · 296 citations · Full text
Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis
Aleena Banerji, Paula J. Busse, Mustafa M. Shennak et al. · New England Journal of Medicine · 2017 · 171 citations · Full text
Hereditary Angioedema with Normal C1 Inhibitor: Clinical Symptoms and Course
Konrad Bork, Döndü Gül, Jochen Hardt et al. · The American Journal of Medicine · 2007 · 136 citations